Deal Watch: Oncternal Goes Public Via Reverse Merger With GTx

11 Mar 2019

• By Joseph Haas, Jo Shorthouse, and Eleanor Malone

All-stock transaction combines privately held Oncternal with GTx, which had been considering its strategic alternatives. Biogen acquires gene therapy biotech Nightstar, MaxCyte and Kite expand their CAR-T partnership.

Deal Watch: Oncternal Goes Public Via Reverse Merger With GTx

More from Deals

More from Business